Originator and biosimilar market dynamics
Godman, Brian (2021) Originator and biosimilar market dynamics. In: Biosimilars Latam - Brazil 2021, 2021-08-25 - 2021-08-26, Online Event.
Preview |
Text.
Filename: Godman_LATAM_2021_Originator_and_biosimilar_market.pdf
Final Published Version Download (1MB)| Preview |
Preview |
Text.
Filename: Biosimilars_Latam_Brazil_2021_overview.pdf
Final Published Version Download (3MB)| Preview |
Abstract
There is growing expenditure on medicines worldwide, estimated to reach US$1.5 trillion by 2023, with implications for affordability even in high income countries. This increase is driven by biological medicines for complex diseases, including cancer and orphan diseases , which are becoming unaffordable. The costs even for the anti TNFs has resulted in their limited prescribing among a number of Central and Eastern European countries, which is difficult to sustain. Biosimilars offer a way forward to improve the care of patients with proven similar effectiveness and safety between originators and biosimilars, e.g. NOR SWITCH study in Norway.
-
-
Item type: Conference or Workshop Item(Keynote) ID code: 77567 Dates: DateEvent25 August 2021PublishedSubjects: Medicine > Pharmacy and materia medica Department: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences Depositing user: Pure Administrator Date deposited: 26 Aug 2021 11:51 Last modified: 22 Sep 2024 00:33 Related URLs: URI: https://strathprints.strath.ac.uk/id/eprint/77567